Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma-Reference-Cited by-同舟云学术

Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma

Published:2024-02-20 Issue:4 Volume:38 Page:829-839
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chen Zegeng^ORCID,Huang He,Huang Huageng,Yu Le,Weng Huawei,Xiao Jian,Zou Liqun,Zhang Huilai^ORCID,Liang Chaoyong,Zhou Hui,Guo Hongqiang,Wang Zhao,Li Zhiming^ORCID,Wu Tao,Zhang Hongyu,Wu Huijing,Peng Zhigang,Zhai Linzhu,Chen Xinggui,Liang Yang^ORCID,Hong Huangming^ORCID,Lin Tongyu^ORCID

Funder

National Natural Science Foundation of China

Guangdong Science and Technology Department

Medical Science and Technology Foundation of Guangdong Province

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02171-4.pdf

Reference43 articles.

1. Wang H, Fu BB, Gale RP, Liang Y. NK-/T-cell lymphomas. Leukemia. 2021;35:2460–8.

2. Yan Z, Yao Z, Wang H, Yao S, Wang X, Gao Y, et al. Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma. J Clin Virol. 2022;157:105320.

3. Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113:3931–7.

4. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–30.

5. Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17:389–400.